Tonix Pharmaceuticals Holding (TNXP) Capital Expenditures (2011 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Capital Expenditures of $1.7 million for Q1 2026, up 28100.0% year-over-year from N/an in Q1 2025, and down 9.71% quarter-over-quarter from $1.9 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Capital Expenditures (2011 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Capital Expenditures history runs 16 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 28100.0% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $5.1 million (up 27983.33% YoY), while the FY2025 annual figure was $3.4 million, up 2707.5% from the prior year.
- Capital Expenditures for Q1 2026 stood at $1.7 million, down from $1.9 million in the prior quarter.
- The five-year high for Capital Expenditures was $20.2 million in Q1 2022, with the low at -$889000.0 in Q3 2023.
- The 5-year median for Capital Expenditures is $885000.0 (2023), against an average of $3.8 million.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures sank 110.08% in 2023, then soared 62366.67% in 2025.
- Tonix Pharmaceuticals Holding's Capital Expenditures stood at $4.7 million in 2022, then jumped by 63.13% to $7.6 million in 2023, then slumped by 99.96% to $3000.0 in 2024, then jumped by 62366.67% to $1.9 million in 2025, then slipped by 9.71% to $1.7 million in 2026.
- Business Quant data shows TNXP's Capital Expenditures at $1.7 million in Q1 2026, $1.9 million in Q4 2025, and $969000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.46 Mn |
| Jun 30, 2026 | -1.46 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 969,000.00 |
| Sep 30, 2025 | 969,000.00 |
| Jun 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 520,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Dec 31, 2023 | 7.62 Mn |
| Dec 31, 2023 | 7.62 Mn |